secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2025-09-19T23:59:59+00:00
Accession:  0001437749-25-029531
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva prices $9M public offering of 27M shares and warrants at $0.335/unit
---------------------------------------------------------------------------

- 27M shares of common stock plus Series E (5-year term) and Series F (1-year term) warrants, each exercisable for 27M shares at $0.335.
- Gross proceeds of $9M; net proceeds ~$8.1M after fees and expenses.
- Offering expected to close on or about September 22, 2025, subject to customary conditions.
- Proceeds to fund R&D activities and for working capital and general corporate purposes.
- Placement agent: A.G.P./Alliance Global Partners; securities offered under effective shelf registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925029531/0001437749-25-029531-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925029531/rvph20250919_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-029531

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer